News
MORE>
Announcement on the key themes of the 2nd issue of "Organ Transplantation" in 2023
2022-10-11Good news | The latest core indicators of the journal "Organ Transplantation" in our hospital have been greatly improved
2021-12-29Announcement on the key themes of the 1st to 3rd issues of "Organ Transplantation" in 2022
2021-12-20Good news | "Organ Transplantation" won the "Seventh Guangdong Provincial Excellent Science and Technology Journal Award"
2021-12-07Good News | "Organ Transplantation" magazine was selected into the 2021 model case database for the construction of scientific and technological journals in Chinese universities
2021-11-19Topic Gather
MORE>
Organ donation and OPO construction
Research highlights of clinical studies on liver transplantation
Optimization strategy of perioperative management of organ transplantation
Organ transplantation and ischemia-reperfusion injury
Organ xenotransplantation
Accurate prevention and treatment of organ transplantation infection
Guide Consensus
MORE>
Diagnosis and treatment specification for postoperative complications after liver transplantation in China (2019 edition)
Clinical technical operation specification of pancreatic islet transplantation (2019 edition)
Technical operation specification for ABO-incompatible kidney transplantation from relative living donor (2019 edition)
Articles in press have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Display Method:
Display Method:
2022, 13(6): 683-689.
doi: 10.3969/j.issn.1674-7445.2022.06.001
Abstract:
Organ transplantation is an effective treatment for end-stage organ failure. The shortage of donors severely restricts the development of organ transplantation, which is also an unresolved challenge in the reform of organ transplantation in China. To alleviate the shortage of donors, western countries have established the working mechanism of systematic multi-department collaboration (SMDC), which has significantly elevated the level of organ donation by promoting systematic collaboration among relevant departments in all aspects of organ donation. At present, organ donation and transplantation in China have entered the new stage of high-quality development, whereas the level of organ donation remains to be further improved. In this article, the concept of SMDC, the procedures and departments related to SMDC, and the international experience of SMDC were illustrated. Besides, suggestions and proposals were delivered for implementing SMDC in China and constantly developing and modifying the Chinese model of organ donation catering to national conditions.
Organ transplantation is an effective treatment for end-stage organ failure. The shortage of donors severely restricts the development of organ transplantation, which is also an unresolved challenge in the reform of organ transplantation in China. To alleviate the shortage of donors, western countries have established the working mechanism of systematic multi-department collaboration (SMDC), which has significantly elevated the level of organ donation by promoting systematic collaboration among relevant departments in all aspects of organ donation. At present, organ donation and transplantation in China have entered the new stage of high-quality development, whereas the level of organ donation remains to be further improved. In this article, the concept of SMDC, the procedures and departments related to SMDC, and the international experience of SMDC were illustrated. Besides, suggestions and proposals were delivered for implementing SMDC in China and constantly developing and modifying the Chinese model of organ donation catering to national conditions.
2022, 13(6): 690-696.
doi: 10.3969/j.issn.1674-7445.2022.06.002
Abstract:
Human organ donation has entered a high-quality development stage in China, which proposes new requirements for the operation and management of Organ Procurement Organization (OPO). Strengthening cost management of OPO contributes to maintaining healthy and sustainable development of organ donation and highlighting the public welfare and social responsibility of OPO. Therefore, in this article, cost management was taken as the breakthrough point and the concept of value chain cost management was introduced to comprehensively analyze the internal and external value activities of OPO from the aspects of excessively high cost hindering the development of organ donation, value chain cost management promoting high-quality development of organ donation and OPO cost management optimization strategies based on value chain theory, aiming to provide reference for lowering internal cost, expanding the range of cost management and improving industry supervision, thereby reasonably controlling the cost of different activities on the organ donation value chain, achieving the goal of restraining excessive increase of organ procurement cost and promoting healthy development of organ donation and transplantation in China.
Human organ donation has entered a high-quality development stage in China, which proposes new requirements for the operation and management of Organ Procurement Organization (OPO). Strengthening cost management of OPO contributes to maintaining healthy and sustainable development of organ donation and highlighting the public welfare and social responsibility of OPO. Therefore, in this article, cost management was taken as the breakthrough point and the concept of value chain cost management was introduced to comprehensively analyze the internal and external value activities of OPO from the aspects of excessively high cost hindering the development of organ donation, value chain cost management promoting high-quality development of organ donation and OPO cost management optimization strategies based on value chain theory, aiming to provide reference for lowering internal cost, expanding the range of cost management and improving industry supervision, thereby reasonably controlling the cost of different activities on the organ donation value chain, achieving the goal of restraining excessive increase of organ procurement cost and promoting healthy development of organ donation and transplantation in China.
With a focus on Asia and a global perspective: sustainable development of donation after brain death
2022, 13(6): 697-710.
doi: 10.3969/j.issn.1674-7445.2022.06.003
Abstract:
Organ shortage is a prevalent problem within the global transplantation community. World Health Organization (WHO) calls on all countries to achieve self-sufficiency in organ transplantation by reducing the burden of diseases and expanding the effective source of organs in line with ethical principles. Donation after brain death (DBD) remains the major source of transplant organs. In recent years, some Asian countries, including China, have actively promoted the development of donation from deceased organs, which are gradually reshaping the situation of living organ donation as the main source of transplant organs in Asia. The outbreak of COVID-19 in 2020 slowed down the growth trend of global organ donation and transplantation in the past decade. On the premise that the burden of disease and the need for transplantation have not been significantly reduced, the work of organ donation and transplantation in China has been steadily carried out under the guidance of the general policy of epidemic prevention and control and relevant policies of "Put people and their lives first, and adhere to the dynamic zero-Covid policy". This proves to a certain extent that under the continuous drive of the people's medical demands and transplant demands, China has formed an organ donation and transplant work system with resilience, pressure resistance, operational inertia and the survival of the industry. Look at Asia from China, and look at the world from Asia. In this article, by compiling relevant data of organ donation and transplantation in Asia and around the world, the changes of the overall pattern of organ donation and transplantation in Asia during the new developmental trend of global organ transplantation were illustrated, the influencing factors of DBD were identified by analyzing the developmental characteristics and practical experience, and corresponding effective strategies were proposed, aiming to provide professional reference for sustainable and healthy development of organ donation and transplantation in China and throughout Asia.
Organ shortage is a prevalent problem within the global transplantation community. World Health Organization (WHO) calls on all countries to achieve self-sufficiency in organ transplantation by reducing the burden of diseases and expanding the effective source of organs in line with ethical principles. Donation after brain death (DBD) remains the major source of transplant organs. In recent years, some Asian countries, including China, have actively promoted the development of donation from deceased organs, which are gradually reshaping the situation of living organ donation as the main source of transplant organs in Asia. The outbreak of COVID-19 in 2020 slowed down the growth trend of global organ donation and transplantation in the past decade. On the premise that the burden of disease and the need for transplantation have not been significantly reduced, the work of organ donation and transplantation in China has been steadily carried out under the guidance of the general policy of epidemic prevention and control and relevant policies of "Put people and their lives first, and adhere to the dynamic zero-Covid policy". This proves to a certain extent that under the continuous drive of the people's medical demands and transplant demands, China has formed an organ donation and transplant work system with resilience, pressure resistance, operational inertia and the survival of the industry. Look at Asia from China, and look at the world from Asia. In this article, by compiling relevant data of organ donation and transplantation in Asia and around the world, the changes of the overall pattern of organ donation and transplantation in Asia during the new developmental trend of global organ transplantation were illustrated, the influencing factors of DBD were identified by analyzing the developmental characteristics and practical experience, and corresponding effective strategies were proposed, aiming to provide professional reference for sustainable and healthy development of organ donation and transplantation in China and throughout Asia.
2022, 13(6): 711-721.
doi: 10.3969/j.issn.1674-7445.2022.06.004
Abstract:
At present, interdisciplinary integration has become a major feature of the development of science and technology, and multi-disciplinary integration will gradually become the norm. Professional and technological multi-disciplinary integration has unpredictable potential, which will produce new disciplinary frontiers, new fields of science and technology and new patterns of innovation. Organ donation is a new discipline in China's new era. Constructing and promoting an organ donation disciplinary system with the overall goal of safeguarding legal and reasonable rights and interests of donors and their families and the health rights and interests of the recipients are in line with the fundamental requirements of maintaining high-quality development of organ donation and transplantation in China. Meantime, organ donation is a complex medical and social behavior, and organs donated by citizens belong to national resources, which also endows organ donation with a social welfare attribute and relevance with all parties in society. In this article, the essence of current problems encountered during organ donation in China, the whole process of organ donation and theoretical knowledge, professional skills and personnel support required by donors in different clinical stages were analyzed to illustrate the necessity and feasibility of establishing an organ donation disciplinary system based on multi-disciplinary integration. Besides, how to integrate organ donation disciplinary construction into the national policy was also investigated. Taking safeguarding the rights and interests of donors, family members and recipients as the core and taking organ donation and transplantation as the main line, cooperative principles of co-creation, co-construction, mutual promotion, sharing and win-win should be upheld, aiming to promote multi-disciplinary integration and comprehensive talent cultivation of organ donation, jointly enhance the recognition rate and donation rate of organ donation, and make organ donation widely recognized by citizens from all walks of life.
At present, interdisciplinary integration has become a major feature of the development of science and technology, and multi-disciplinary integration will gradually become the norm. Professional and technological multi-disciplinary integration has unpredictable potential, which will produce new disciplinary frontiers, new fields of science and technology and new patterns of innovation. Organ donation is a new discipline in China's new era. Constructing and promoting an organ donation disciplinary system with the overall goal of safeguarding legal and reasonable rights and interests of donors and their families and the health rights and interests of the recipients are in line with the fundamental requirements of maintaining high-quality development of organ donation and transplantation in China. Meantime, organ donation is a complex medical and social behavior, and organs donated by citizens belong to national resources, which also endows organ donation with a social welfare attribute and relevance with all parties in society. In this article, the essence of current problems encountered during organ donation in China, the whole process of organ donation and theoretical knowledge, professional skills and personnel support required by donors in different clinical stages were analyzed to illustrate the necessity and feasibility of establishing an organ donation disciplinary system based on multi-disciplinary integration. Besides, how to integrate organ donation disciplinary construction into the national policy was also investigated. Taking safeguarding the rights and interests of donors, family members and recipients as the core and taking organ donation and transplantation as the main line, cooperative principles of co-creation, co-construction, mutual promotion, sharing and win-win should be upheld, aiming to promote multi-disciplinary integration and comprehensive talent cultivation of organ donation, jointly enhance the recognition rate and donation rate of organ donation, and make organ donation widely recognized by citizens from all walks of life.
2022, 13(6): 722-729.
doi: 10.3969/j.issn.1674-7445.2022.06.005
Abstract:
Machine learning can efficiently extract the features and establish associations from complex databases, and better predict changes in clinical diseases by constructing models. Liver transplantation is one of the efficacious therapeutic options for all types of end-stage liver diseases and primary liver cancer. Nevertheless, it also faces multiple challenges. How to more effectively allocate the organs, expand the donor liver pool, evaluate the optimal donor-recipient matching, predict the complications after liver transplantation, disease recurrence and long-term survival have been the hot spots and difficulties. In recent years, certain progress has been made in the application of machine learning in the field of liver transplantation, showcasing promising prospect. In this article, the application status and prospect of machine learning in organ allocation before liver transplantation, donor liver evaluation, prediction of perioperative complications, blood transfusion, postoperative new disease, disease recurrence, acute rejection and long-term survival were reviewed, aiming to provide ideas and direction for subsequent investigations.
Machine learning can efficiently extract the features and establish associations from complex databases, and better predict changes in clinical diseases by constructing models. Liver transplantation is one of the efficacious therapeutic options for all types of end-stage liver diseases and primary liver cancer. Nevertheless, it also faces multiple challenges. How to more effectively allocate the organs, expand the donor liver pool, evaluate the optimal donor-recipient matching, predict the complications after liver transplantation, disease recurrence and long-term survival have been the hot spots and difficulties. In recent years, certain progress has been made in the application of machine learning in the field of liver transplantation, showcasing promising prospect. In this article, the application status and prospect of machine learning in organ allocation before liver transplantation, donor liver evaluation, prediction of perioperative complications, blood transfusion, postoperative new disease, disease recurrence, acute rejection and long-term survival were reviewed, aiming to provide ideas and direction for subsequent investigations.
2022, 13(6): 730-735.
doi: 10.3969/j.issn.1674-7445.2022.06.006
Abstract:
With the emergence, development and innovation of minimally invasive surgical and laparoscopic technologies, minimally invasive technology has been gradually applied and promoted in different fields of surgery, and surgical indications have been constantly expanded. Robot-assisted surgical system has become a novel research hotspot due to its precision and minimal invasiveness. At present, robot-assisted surgical system can be applied in complex tumor surgery. How to apply robot-assisted surgery in the field of liver transplantation, especially in the living donor liver hepatectomy, has become a new research direction, which is also a challenge facing multiple scholars. In this article, the advantages of robot-assisted surgery, current status and major difficulties of robot living donor liver hepatectomy were reviewed, and the future of robot living donor liver hepatectomy was predicted, aiming to provide reference for promoting the application of robot-assisted surgery in clinical liver transplantation.
With the emergence, development and innovation of minimally invasive surgical and laparoscopic technologies, minimally invasive technology has been gradually applied and promoted in different fields of surgery, and surgical indications have been constantly expanded. Robot-assisted surgical system has become a novel research hotspot due to its precision and minimal invasiveness. At present, robot-assisted surgical system can be applied in complex tumor surgery. How to apply robot-assisted surgery in the field of liver transplantation, especially in the living donor liver hepatectomy, has become a new research direction, which is also a challenge facing multiple scholars. In this article, the advantages of robot-assisted surgery, current status and major difficulties of robot living donor liver hepatectomy were reviewed, and the future of robot living donor liver hepatectomy was predicted, aiming to provide reference for promoting the application of robot-assisted surgery in clinical liver transplantation.
2022, 13(6): 736-741.
doi: 10.3969/j.issn.1674-7445.2022.06.007
Abstract:
The implementation of living donor liver transplantation not only extends the number of donors and effectively alleviates the shortage of organ donation, but also reduces the fatality of patients on the waiting list for liver transplantation. In recent years, with persistent development of laparoscopic techniques and instruments, laparoscopic donor liver hepatectomy has been widely applied in the field of living donor liver transplantation, which is also one of the research hotspots. It has multiple advantages of mild trauma, slight pain, accelerated postoperative recovery for the donors and slight psychological burden, etc. However, due to strict screening criteria for donors, complicated procedures and long learning curve, it has been carried out in a few transplantation centers nationwide. In this article, the development history and current status, specific surgical patterns, the problems and challenges of laparoscopic living donor liver procurement for liver transplantation were introduced, and the development direction of laparoscopic living donor liver procurement was predicted, aiming to provide reference for accelerating the development and enhancing clinical prognosis of living donor liver transplantation.
The implementation of living donor liver transplantation not only extends the number of donors and effectively alleviates the shortage of organ donation, but also reduces the fatality of patients on the waiting list for liver transplantation. In recent years, with persistent development of laparoscopic techniques and instruments, laparoscopic donor liver hepatectomy has been widely applied in the field of living donor liver transplantation, which is also one of the research hotspots. It has multiple advantages of mild trauma, slight pain, accelerated postoperative recovery for the donors and slight psychological burden, etc. However, due to strict screening criteria for donors, complicated procedures and long learning curve, it has been carried out in a few transplantation centers nationwide. In this article, the development history and current status, specific surgical patterns, the problems and challenges of laparoscopic living donor liver procurement for liver transplantation were introduced, and the development direction of laparoscopic living donor liver procurement was predicted, aiming to provide reference for accelerating the development and enhancing clinical prognosis of living donor liver transplantation.
2022, 13(6): 742-748.
doi: 10.3969/j.issn.1674-7445.2022.06.008
Abstract:
Liver tumors can be divided into benign and malignant types. Benign liver tumors are relatively common, which are mainly treated with follow-up observation and interventional therapy, and surgical resection should be performed for few cases. Liver transplantation can effectively treat end-stage liver diseases, whereas it is seldom applied in the treatment of benign liver tumors. Liver transplantation is only considered for benign liver tumors with huge space-occupying compression, liver failure, the risk of tumor rupture and bleeding or malignant transformation. Compared with malignant tumors and chronic liver failure, liver transplantation yields an equivalent risk for benign liver tumors, favorable clinical prognosis and long-term survival. However, comprehensive evaluation should be delivered before liver transplantation for benign liver tumors, and extensive attention should be paid to the difficulty of donor liver matching in the new situation. In this article, research progress on liver transplantation for benign liver tumors including hepatic hemangioma, polycystic liver, hepatocellular adenoma, hepatic mesenchymal hamartoma was reviewed, aiming to provide reference for liver transplantation in the treatment of benign liver tumors.
Liver tumors can be divided into benign and malignant types. Benign liver tumors are relatively common, which are mainly treated with follow-up observation and interventional therapy, and surgical resection should be performed for few cases. Liver transplantation can effectively treat end-stage liver diseases, whereas it is seldom applied in the treatment of benign liver tumors. Liver transplantation is only considered for benign liver tumors with huge space-occupying compression, liver failure, the risk of tumor rupture and bleeding or malignant transformation. Compared with malignant tumors and chronic liver failure, liver transplantation yields an equivalent risk for benign liver tumors, favorable clinical prognosis and long-term survival. However, comprehensive evaluation should be delivered before liver transplantation for benign liver tumors, and extensive attention should be paid to the difficulty of donor liver matching in the new situation. In this article, research progress on liver transplantation for benign liver tumors including hepatic hemangioma, polycystic liver, hepatocellular adenoma, hepatic mesenchymal hamartoma was reviewed, aiming to provide reference for liver transplantation in the treatment of benign liver tumors.
2022, 13(6): 749-756.
doi: 10.3969/j.issn.1674-7445.2022.06.009
Abstract:
Objective To investigate the role and mechanism of growth differentiation factor (GDF) 15 in ischemia-reperfusion injury (IRI) during kidney transplantation. Methods Nine wild type donor mice and 9 wild type recipient mice were selected. The renal graft of 3 recipient mice were harvested at 4, 24 and 72 h after transplantation. GDF family transcriptome analysis was carried out, and the expression of GDF15 in renal tissues of each group were detected. Five wild type donor mice, 5 GDF15 knockout donor mice and 10 wild type recipient mice were selected. According to the experimental scheme, the mice were divided into wild type sham operation group, wild type transplantation group, GDF15 knockout sham operation group and GDF15 knockout transplantation group. Serum and renal tissue samples were extracted 72 h after transplantation. The renal function, renal tubular injury, inflammatory cell infiltration, inflammatory factors, Toll-like receptor 4 (TLR4) and nuclear factor (NF)-κB expression level were compared in each group. Nine wild type donor mice, 9 GDF15 knockout donor mice and 18 wild type recipient mice were selected. According to the experimental scheme, the mice were divided into wild type transplantation group and GDF15 knockout transplantation group, and the survival rate of two group after kidney transplantation was observed. Results Transcriptome sequencing of renal graft tissues indicated that GDF15 was the most up-regulated GDF family gene, which was mainly expressed in renal tubules. Compared with the sham operation group, the renal function of mice was declined in the transplantation group. Compared with the wild type transplantation group, the serum creatinine and blood urea nitrogen levels of mice were significantly up-regulated in the GDF15-knockout transplantation group (both P < 0.05). The 1-week survival rate of mice was 87.6% in the wild type transplantation group and 41.8% in the GDF15 knockout transplantation group. In the GDF15 knockout transplantation group, the expression level of kidney injury molecule (KIM)-1 was up-regulated, and the renal tubule injury score was increased. In the wild type transplantation group, the renal tubules were dissolved or necrotized, and tubular formation was seen in the extramedullary and cortex area, whereas tubular necrosis and tubular formation were more evident in the GDF15 knockout transplantation group. The expression levels of myeloperoxidase (MPO) and F4/80 were up-regulated in the transplantation group, and the inflammatory cell infiltration was aggravated in the GDF15 knockout transplantation group. Compared with the sham operation group, the expression levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 in the transplantation group were up-regulated. Compared with the wild type transplantation group, the expression levels of TNF-α, IL-1β and IL-6 were also up-regulated in the GDF15 knockout transplantation group (all P < 0.05). In the transplantation group, the expression levels of TLR4 and NF-κB in the renal graft tissues were higher than those in the sham operation group. In the GDF15 knockout transplantation group, the expression levels of TLR4 and NF-κB in the renal graft tissues were higher compared with those in the wild type transplantation group. Conclusions GDF15 may alleviate the IRI of renal graft probably via inhibiting the TLR4-NF-κB signaling pathway.
2022, 13(6): 757-763.
doi: 10.3969/j.issn.1674-7445.2022.06.010
Abstract:
Objective To evaluate the effect of united Organ Procurement Organization (OPO) on organ donation and procurement quality control indexes. Methods The differences in organ donation workload, work efficiency, organ donation quality control and management indexes in a united OPO-led hospital were retrospectively analyzed before (n=36) and after (n=33) the establishment of united OPO. Results After the establishment of united OPO, the organ donation workload and efficiency were enhanced. The annual donation cases, annual organ procurement cases, average organ procurement cases per day, organ donation rate of per million population (PMP), coordinator work efficiency index and other indexes were further improved. Before the establishment of united OPO, the donation conversion rate was 26.5%, and increased up to 29.0% after the establishment of united OPO. The average organ yield rate remained higher than 3.3 before and after the establishment of united OPO. No significant differences were noted in the utilization rate of procured organs, proportion of marginal donor organs, positive rate for pathogen culture in organ preservation solution, the incidence of primary nonfunction (PNF) and delayed graft function (DGF) before and after the establishment of united OPO (all P > 0.05). The biopsy rates of donated organs were 27.7% and 58.3%, and the organ outflow rates were 83.1% and 47.8% before and after the establishment of united OPO, and the differences were statistically significant (both P < 0.05). Conclusions The establishment of united OPO contributes to promoting efficient development of organ donation and procurement, lowering the cost of organ donation and procurement, and improving the effectiveness, quality control and management levels of organ donation and procurement.
2022, 13(6): 764-769.
doi: 10.3969/j.issn.1674-7445.2022.06.011
Abstract:
Objective To introduce the simplified "All in one" hepatic vein reconstruction in right split liver transplantation, and to investigate the clinical indications, surgical procedures and clinical prognosis of this technique. Methods Clinical data of 2 recipients undergoing right split liver transplantation were retrospectively analyzed, and the simplified "All in one" hepatic vein reconstruction of right liver lobe was summarized and analyzed. In 2 cases, the right liver lobe was split in vivo. In case 1, the liver parenchyma was split until the first and second porta hepatis, and then the liver was obtained by whole-liver perfusion after cutting off the right hepatic duct, and the hepatic blood vessels were isolated ex vivo. In case 2, the left liver lobe was obtained during splitting in vivo and the right liver lobe was obtained after perfusion in vivo. During donor liver splitting in two cases, the common trunk of the middle hepatic vein was maintained in the left liver lobe, the S5 and S8 hepatic veins of the right liver lobe were reconstructed by the same donor iliac artery, and directly anastomosed with the gap between the left and middle hepatic veins of the inferior vena cava, thus reconstructing the integrity of the posterior inferior vena cava. Results The simplified "All in one" right hepatic vein reconstruction was adopted. The anhepatic phase of two recipients undergoing liver transplantation was 41 and 36 min. After the liver was incised open, the blood flow of the donor liver was normal, the iliac artery bypass was fully filled, liver congestion or swelling was not observed, and liver function was properly recovered after surgery. Two recipients were subject to postoperative follow-up for 23 and 10 months, respectively, No complications related to hepatic venous outflow tracts were noted, such as hepatic vein and inferior vena cava. Conclusions "All in one" hepatic vein reconstruction may simplify the procedures of hepatic venous outflow tract reconstruction, shorten the anhepatic phase and reduce the incidence of postoperative hepatic vein complications in complete right liver split transplantation.
2022, 13(6): 770-775.
doi: 10.3969/j.issn.1674-7445.2022.06.012
Abstract:
Objective To compare the clinical efficacy between Clamshell incision and bilateral posterolateral incision in the sequential double lung transplantation for end-stage lung disease. Methods Clinical data of 120 recipients undergoing double lung transplantation were retrospectively analyzed. All recipients were divided into bilateral posterolateral incision group (n=108) and Clamshell incision group (n=12) according to different surgical methods. Intraoperative parameters were collected and statistically compared between two groups, including operation time, amount of blood loss, amount of blood transfusion, use of extracorporeal membrane oxygenation (ECMO) or not, cold ischemia time on the first side, and cold ischemia time on the second side. Postoperative parameters were also compared between two groups, including the length of hospital stay, length of intensive care unit (ICU) stay, tracheal intubation duration, ECMO duration, forced vital capacity (FVC), forced expiratory volume in one second (FEV1), incidence of anastomotic stenosis, incidence of bronchopleural fistula, perioperative fatality, and 6-minute walk test for the first time after operation. Results In the Clamshell incision group, the amount of blood loss and blood transfusion was significantly higher than those in the bilateral posterolateral incision group (both P < 0.05). The proportion of ECMO and cold ischemia time on the second side in the Clamshell incision group were significantly lower or shorter than those in the bilateral posterolateral incision group (both P < 0.05). In the Clamshell incision group, the tracheal intubation duration and ECMO duration were significantly shorter compared with those in bilateral posterolateral incision group (both P < 0.05). Conclusions Both Clamshell incision and bilateral posterolateral incision are safe and effective in sequential double lung transplantation. Bilateral posterolateral incision approach can significantly reduce the amount of blood loss and blood transfusion of the recipients without significantly prolonging the operation time. Compared with bilateral posterolateral incision approach, the cold ischemia time of lung graft, tracheal intubation duration and ECMO duration are significantly shortened via the Clamshell incision.
2022, 13(6): 776-782.
doi: 10.3969/j.issn.1674-7445.2022.06.013
Abstract:
Objective To explore the major risk factors of post transplantation diabetes mellitus (PTDM) and analyze the correlation between tacrolimus and PTDM after kidney transplantation. Methods Clinical data of 123 kidney transplant recipients were collected. All recipients were divided into the PTDM group (n=19) and non-PTDM group (n=104). Clinical data of all recipients in two groups were analyzed. The risk factors of PTDM were analyzed by binary logistic regression. Twenty-four mice were evenly divided into the control group (normal saline), low-dose tacrolimus (0.1 mg/kg), medium-dose tacrolimus (0.75 mg/kg) and high-dose tacrolimus groups (1.5 mg/kg). The solutions were given twice a day. The effect of tacrolimus on blood glucose metabolism in mice was evaluated. Results The incidence of PTDM was 15.4% (19/123) within 1 year after kidney transplantation. Age≥48 years old and the trough concentration of tacrolimus≥9 ng/mL within 3 months after kidney transplantation were the risk factors for PTDM after kidney transplantation (both P < 0.05). The fasting blood glucose levels of mice after administration in the low-, medium- and high-dose tacrolimus groups were significantly lower than those before administration (all P < 0.05) in a dose-independent manner (P=0.750). In the low-, medium- and high-dose tacrolimus groups, the postprandial blood glucose levels of mice after administration were significantly higher than those before administration (all P < 0.05) in a dose-dependent manner (P=0.012). Conclusions Tacrolimus is intimately correlated with the incidence of PTDM after kidney transplantation. Age≥48 years old and the trough concentration of tacrolimus ≥9 ng/mL within 3 months after kidney transplantation are the independent risk factors of PTDM. Tacrolimus affects the postprandial blood glucose levels of mice in a dose-dependent manner.
2022, 13(6): 783-790.
doi: 10.3969/j.issn.1674-7445.2022.06.014
Abstract:
Objective To systematically analyze the research status of human organ donation coordinator at home and abroad in recent years, aiming to provide novel ideas for subsequent research. Methods Studies related to organ donation coordinator searched from CNKI, VIP, Wanfang and Web of Science (SCI/SSCI/CPCI) core collection databases from January 1, 2009 to December 31, 2021 were collected as samples, and CiteSpace software was used for visual analysis from the aspects of the number of articles, authors, countries, publishing organizations and keywords, etc. Results A total of 47 valid Chinese articles and 43 English articles were included. The number of articles was elevated in a fluctuating pattern in recent 12 years. Eleven core authors published articles in Chinese journals, and the top three authors were Ye Qifa, Huang Wei and Si Jing. Five core authors published articles in English journals and the top three authors were Konaka, Fukushima and Kato. Wuhan University Affiliated Hospital and its research center published the largest number of articles in China, followed by Ningbo Urology & Nephrology Hospital and Human Organ Donation Office, Institute of Hepatobiliary Diseases of Central South Hospital of Wuhan University, and Institute of Hepatobiliary Diseases of Central South Hospital. These institutions were distributed in a disperse pattern and have not formed a cooperative group. International institutions with the highest number of articles were University of Warsaw in Poland, Osaka University in Japan, Children's Hospital of Eastern Ontario in Canada, and Polish Transplant Coordinating Ctr Poltransplant. The top three countries regarding the number of English articles were the United States, Japan and China. Keywords cluster analysis found that the research mainly focused on seven thematic groups including the emergence and development, roles and functions, professional capability and professional identity, team building, current work status, professional training and health management of organ donation coordinators. Conclusions The research related to organ donation coordinators at home and abroad shows a good development trend, whereas the research contents remain to be classified and expanded. Subsequently, different research institutions and countries should establish more extensive exchange and cooperation, and constantly drive the research advancement in related fields.
2022, 13(6): 791-796.
doi: 10.3969/j.issn.1674-7445.2022.06.015
Abstract:
Objective To investigate the anatomical classification of left intrahepatic bile duct (LHD) and the pattern of bile duct reconstruction during pediatric split liver transplantation and their relationship with postoperative biliary complications. Methods Clinical data of 75 pediatric recipients undergoing split liver transplantation were analyzed retrospectively. Before splitting the donor liver, iopromide injection was used for retrograde cholangiography through the common bile duct. According to the patterns of intrahepatic bile ducts in the second, third and fourth segments, the anatomical classification of LHD of the donor liver was determined. The biliary reconstruction regimens for different classification types of LHD were summarized. The incidence and treatment of biliary complications after pediatric split liver transplantation were analyzed. Results Among 75 donor livers, the anatomical classification of LHD included 57 cases (76%) of type Ⅰ, 9 cases (12%) of type Ⅱ, 4 cases (5%) of type Ⅲ and 5 cases (7%) of type Ⅳ LHD, respectively. Among 75 pediatric recipients, 69 cases (53 cases of type Ⅰ, 8 type Ⅱ, 4 type Ⅲ and 4 type Ⅳ) underwent the left hepatic duct-jejunum Roux-en-Y anastomosis, 1 case received common bile duct-jejunum Roux-en-Y anastomosis (type Ⅳ), and 5 cases underwent the left hepatic duct-common bile duct end-to-end anastomosis (4 cases of type Ⅰ and 1 type Ⅱ). Postoperative biliary complications occurred in 6 cases (8%), including 3 cases of biliary anastomotic stenosis, 2 cases of biliary anastomotic leakage and 1 case of bile leakage on the hepatic resection surface. Among 6 recipients, 4 cases were classified as type Ⅰ and 2 cases of type Ⅲ LHD. No significant difference was observed in the incidence of biliary complications between typical type and anatomical variant type of LHD (all P > 0.05). Among 3 recipients with biliary anastomotic stenosis, 2 cases underwent percutaneous transhepatic cholangial and drainage (PTCD) and 1 case repeatedly received biliary-intestinal anastomosis. Two cases of biliary anastomotic leakage underwent PTCD and 1 case of bile leakage on the hepatic resection surface received local drainage. All 6 children survived after treatment. Conclusions Anatomical variation of LHD can be observed in 24% of donor livers, and type Ⅱ accounts for the highest proportion of 12%. Prior to donor liver splitting, routine cholangiography and fine biliary anastomosis may effectively lower the incidence of biliary complications. The incidence of postoperative biliary complications is not significantly associated with the anatomical classification of LHD.
2022, 13(6): 797-802.
doi: 10.3969/j.issn.1674-7445.2022.06.016
Abstract:
Objective To identify the risk factors of prolonged mechanical ventilation (PMV) after lung transplantation. Methods Clinical data of 90 recipients undergoing lung transplantation were retrospectively analyzed. According to the duration of invasive mechanical ventilation after operation, all recipients were divided into the PMV group (ventilation duration > 48 h, n=30) and control group (ventilation duration≤48 h, n=60). Perioperative parameters were compared between two groups, including preoperative parameters [serum creatinine, estimated glomerular filtration rate (eGFR)], intraoperative parameters (cold ischemia time of donor lung, blood loss), and postoperative parameters [the first red blood cell, white blood cell, platelet count, hemoglobin, C-reactive protein, serum creatinine, total bilirubin, alanine aminotransferase (ALT), oxygenation index, eGFR and the mean arterial pressure in intensive care unit (ICU)]. The risk factors of PMV after lung transplantation were assessed by multivariate logistic regression analysis. Results Preoperative serum creatinine level in the PMV group was 62 (53, 67) μmol/L, significantly higher than 57 (47, 62) μmol/L in the control group. Preoperative eGFR in the PMV group was 97 (93, 107) mL/min, significantly lower than 106 (102, 116) mL/min in the control group. The first postoperative oxygenation index in the PMV group was 196 (157, 286) mmHg, significantly lower than 250 (199, 354) mmHg in the control group (all P < 0.05). Multivariate analysis showed that the first increase of postoperative total bilirubin, the first decrease of postoperative oxygenation index and preoperative eGFR decrease were the independent risk factors for PMV following lung transplantation. Conclusions The first increase of postoperative total bilirubin, the first decrease of postoperative oxygenation index and preoperative eGFR decrease are the independent risk factors for PMV after lung transplantation.
2022, 13(6): 803-809.
doi: 10.3969/j.issn.1674-7445.2022.06.017
Abstract:
Objective To investigate the guiding role of quantitative evaluation system of immune status in the individualized management of immunosuppressants for the recipients after liver transplantation. Methods Clinical data of 239 liver transplant recipients were retrospectively analyzed. MingDao Immune Cell Analysis (MICA) was established. All recipients were divided into two groups according to the adjustment regimens of immunosuppressants. The immunosuppressant regimen was adjusted according to MingDao Immune System Score (MISS) in the MISS group (n=84), and the medication plan was empirically adjusted during the same period in the control group (n=155). According to the time of postoperative detection (t), the recipients in the MISS group were divided into subgroup A (t ≤ 28 d, n=78), subgroup B (28 d < t ≤ 6 months, n=68), subgroup C (6 months < t ≤ 12 months, n=18), subgroup D (12 months < t ≤ 24 months, n=18) and subgroup E (t > 24 months, n=19). In the MISS group, postoperative MISS scores of recipients in subgroups A-E were analyzed. The incidence of acute rejection and opportunistic infection and the overall survival rate were statistically compared between the MISS and control groups. Results The MISS scores in subgroups A-E were -7.0 (-13.2, -2.0), -2.0 (-5.8, 1.8), -0.5 (-7.3, 2.8), -2.0 (-4.5, 3.3) and -3.0 (-6.0, 1.0), respectively. The immune status of the recipients was gradually improved over postoperative time, and the difference between two groups was statistically significant (P < 0.05). In the MISS group, 15% (13/84) of the recipients developed acute rejection, and 27% (42/155) in the control group, and the difference was statistically significant (P < 0.05). In the MISS group, the MISS score of the recipients with acute rejection was 0 (-2.5, 3.5), and -5.0 (-12.0, -1.0) for their counterparts without acute rejection, and the difference was statistically significant (P < 0.05). In the MISS group, 2% (2/84) of the recipients presented with postoperative opportunistic infection, and 9% (14/155) in the control group, and the difference was statistically significant (P < 0.05). In the MISS group, the 1- and 3-year overall survival rates were 86.9% and 79.8%, and 83.2% and 76.8% in the control group, and no significant difference was observed between two groups (P > 0.05). Conclusions MICA and MISS score may reflect the immune status of liver transplant recipients, and guide the individualized management of administration of immunosuppressants after liver transplantation.
2022, 13(6): 810-817.
doi: 10.3969/j.issn.1674-7445.2022.06.018
Abstract:
Xenotransplantation is one of the potential approaches to mitigate the shortage of donor kidneys. With the progress of gene modification techniques and the development of immunosuppressant, significant progress has been made in the preclinical research of genetically modified pig to non-human primate (NHP) xenotransplantation. The longest survival time of recipients exceeds 500 d. However, the number of recipients surviving for over 1 year is extremely low, and most recipients die within postoperative 1-2 months. Therefore, several problems remain to be clarified and resolved. In this article, rejection, refractory coagulation dysfunction, persistent inflammation, the selection of immunosuppressant, the selection of clinical recipients and the risk of cross-infection in genetically modified pig to NHP xenotransplantation were reviewed, and current problems and potential solutions of genetically modified pig to NHP xenotransplantation were summarized, aiming to provide reference for promoting xenotransplantation in clinical settings.
Xenotransplantation is one of the potential approaches to mitigate the shortage of donor kidneys. With the progress of gene modification techniques and the development of immunosuppressant, significant progress has been made in the preclinical research of genetically modified pig to non-human primate (NHP) xenotransplantation. The longest survival time of recipients exceeds 500 d. However, the number of recipients surviving for over 1 year is extremely low, and most recipients die within postoperative 1-2 months. Therefore, several problems remain to be clarified and resolved. In this article, rejection, refractory coagulation dysfunction, persistent inflammation, the selection of immunosuppressant, the selection of clinical recipients and the risk of cross-infection in genetically modified pig to NHP xenotransplantation were reviewed, and current problems and potential solutions of genetically modified pig to NHP xenotransplantation were summarized, aiming to provide reference for promoting xenotransplantation in clinical settings.
2022, 13(6): 818-824.
doi: 10.3969/j.issn.1674-7445.2022.06.019
Abstract:
Biliary atresia is a rare congenital disease of children with unknown pathogenesis and biliary obstruction, which is mainly manifested with progressive inflammation and fibrous obstruction of the biliary system inside and outside the liver, and subsequently develop into cholestatic cirrhosis and liver failure. Although biliary atresia is rare, it is the most common cause of cholestasis during the infancy period. If surgical treatment were not performed (such as Kasai operation and liver transplantation), children may die in a short period of time. Kasai operation can improve biliary drainage, whereas it fails to change the outcomes of children with biliary atresia. Most of them will still suffer from persistent liver injury due to cholestasis, and eventually require liver transplantation. At present, there is no consensus on whether Kasai operation should be performed prior to liver transplantation. In this article, research progress on the diagnosis and surgical treatment of biliary atresia was reviewed, aiming to provide reference for clinical diagnosis and treatment of biliary atresia and improve the survival of children with biliary atresia.
Biliary atresia is a rare congenital disease of children with unknown pathogenesis and biliary obstruction, which is mainly manifested with progressive inflammation and fibrous obstruction of the biliary system inside and outside the liver, and subsequently develop into cholestatic cirrhosis and liver failure. Although biliary atresia is rare, it is the most common cause of cholestasis during the infancy period. If surgical treatment were not performed (such as Kasai operation and liver transplantation), children may die in a short period of time. Kasai operation can improve biliary drainage, whereas it fails to change the outcomes of children with biliary atresia. Most of them will still suffer from persistent liver injury due to cholestasis, and eventually require liver transplantation. At present, there is no consensus on whether Kasai operation should be performed prior to liver transplantation. In this article, research progress on the diagnosis and surgical treatment of biliary atresia was reviewed, aiming to provide reference for clinical diagnosis and treatment of biliary atresia and improve the survival of children with biliary atresia.
2016, 7(5): 327-331.
doi: 10.3969/j.issn.1674-7445.2016.05.001
摘要：
为提高临床医师对肾移植受者免疫抑制治疗的认识, 规范国内肾移植受者管理, 帮助医师在肾移植临床实践中做出合理决策, 我们组织专家制订了《中国肾移植受者免疫抑制治疗指南(2016版)》。该指南以《2009版改善全球肾病预后组织(KDIGO)肾移植受者管理指南》为主要参考, 结合我国的临床实践经验, 希望能为相关临床科室提供工作指引。
为提高临床医师对肾移植受者免疫抑制治疗的认识, 规范国内肾移植受者管理, 帮助医师在肾移植临床实践中做出合理决策, 我们组织专家制订了《中国肾移植受者免疫抑制治疗指南(2016版)》。该指南以《2009版改善全球肾病预后组织(KDIGO)肾移植受者管理指南》为主要参考, 结合我国的临床实践经验, 希望能为相关临床科室提供工作指引。
2019, 10(1): 32-35.
doi: 10.3969/j.issn.1674-7445.2019.01.004
摘要：
我国的器官移植事业正处于由数量规模型发展向高质量和高科技含量提升、由移植大国向移植强国冲刺的历史关键时期。在2018年中华医学会器官移植学年会上，主任委员石炳毅教授从中国器官捐献与移植体系建设、中国器官移植发展现状两大方面，作了“继往开来，中国器官移植的发展现状”的报告。新的历史时期赋予我们新的历史使命，器官移植学分会要主动作为，推动科学发展，为贯彻新理念、拓宽新视野、实现新愿景而努力奋斗。
我国的器官移植事业正处于由数量规模型发展向高质量和高科技含量提升、由移植大国向移植强国冲刺的历史关键时期。在2018年中华医学会器官移植学年会上，主任委员石炳毅教授从中国器官捐献与移植体系建设、中国器官移植发展现状两大方面，作了“继往开来，中国器官移植的发展现状”的报告。新的历史时期赋予我们新的历史使命，器官移植学分会要主动作为，推动科学发展，为贯彻新理念、拓宽新视野、实现新愿景而努力奋斗。
2019, 10(3): 213-226.
doi: 10.3969/j.issn.1674-7445.2019.03.001
摘要：
为了进一步规范器官移植免疫抑制剂的临床应用，中华医学会器官移植学分会组织全国31家移植中心的器官移植专家，从器官移植免疫诱导药物应用技术规范、器官移植维持期免疫抑制剂应用技术规范、器官移植常用免疫抑制方案技术规范、器官移植免疫抑制剂血药浓度监测技术规范、器官移植药物性肝肾损伤治疗技术规范等方面，制订本规范，以帮助器官移植工作者规范和优化器官移植免疫抑制剂的临床应用。
为了进一步规范器官移植免疫抑制剂的临床应用，中华医学会器官移植学分会组织全国31家移植中心的器官移植专家，从器官移植免疫诱导药物应用技术规范、器官移植维持期免疫抑制剂应用技术规范、器官移植常用免疫抑制方案技术规范、器官移植免疫抑制剂血药浓度监测技术规范、器官移植药物性肝肾损伤治疗技术规范等方面，制订本规范，以帮助器官移植工作者规范和优化器官移植免疫抑制剂的临床应用。
2016, 7(6): 417-426.
doi: 10.3969/j.issn.1674-7445.2016.06.002
摘要：
活体供肾移植经历半个多世纪的发展，已成为终末期肾病患者的重要治疗手段。在我国，亲属活体器官捐献肾移植作为家庭自救的方式之一，近年来已成为肾脏供体来源的重要补充部分。本指南以世界卫生组织《人体器官移植指导原则》(1991)、中华人民共和国国务院《人体器官移植条例》(2007)以及国家卫生部《关于规范活体器官移植的若干规定》(2010)为法律依据，在《中国活体供肾移植指南》(2009)的基础上进行更新。内容包括活体供肾移植的伦理学、供者与受者的医学评估、活体供肾摘取原则与手术方式、供者近期与远期并发症以及供者的长期随访等。
活体供肾移植经历半个多世纪的发展，已成为终末期肾病患者的重要治疗手段。在我国，亲属活体器官捐献肾移植作为家庭自救的方式之一，近年来已成为肾脏供体来源的重要补充部分。本指南以世界卫生组织《人体器官移植指导原则》(1991)、中华人民共和国国务院《人体器官移植条例》(2007)以及国家卫生部《关于规范活体器官移植的若干规定》(2010)为法律依据，在《中国活体供肾移植指南》(2009)的基础上进行更新。内容包括活体供肾移植的伦理学、供者与受者的医学评估、活体供肾摘取原则与手术方式、供者近期与远期并发症以及供者的长期随访等。
2019, 10(2): 122-127.
doi: 10.3969/j.issn.1674-7445.2019.02.003
摘要：
为了进一步规范中国公民逝世后器官捐献的流程，中华医学会器官移植学分会组织器官移植和器官捐献相关专家，从报名登记、捐献评估、捐献确认、器官获取、器官分配、遗体处理、人道救助、捐献文书归档等8个环节，制定中国公民逝世后器官捐献流程和规范(2019版)。
为了进一步规范中国公民逝世后器官捐献的流程，中华医学会器官移植学分会组织器官移植和器官捐献相关专家，从报名登记、捐献评估、捐献确认、器官获取、器官分配、遗体处理、人道救助、捐献文书归档等8个环节，制定中国公民逝世后器官捐献流程和规范(2019版)。
2019, 10(2): 142-148.
doi: 10.3969/j.issn.1674-7445.2019.02.005
摘要：
为了进一步规范中国实体器官移植（SOT）受者巨细胞病毒（CMV）感染的诊断和治疗，中华医学会器官移植学分会组织器官移植专家、感染病学专家及呼吸内科专家，在《实体器官移植受者巨细胞病毒感染诊疗指南（2017版）》的基础上，从CMV感染的主要危险因素、实验室诊断、临床类型、预防方案，CMV病的治疗，儿童SOT术后CMV感染或CMV病的防治，CMV肺炎合并伊氏肺孢子菌肺炎的防治等方面，制订本规范，以期为我国SOT术后CMV感染的规范化防治提供指导意见。
为了进一步规范中国实体器官移植（SOT）受者巨细胞病毒（CMV）感染的诊断和治疗，中华医学会器官移植学分会组织器官移植专家、感染病学专家及呼吸内科专家，在《实体器官移植受者巨细胞病毒感染诊疗指南（2017版）》的基础上，从CMV感染的主要危险因素、实验室诊断、临床类型、预防方案，CMV病的治疗，儿童SOT术后CMV感染或CMV病的防治，CMV肺炎合并伊氏肺孢子菌肺炎的防治等方面，制订本规范，以期为我国SOT术后CMV感染的规范化防治提供指导意见。
2019, 10(5): 505-512.
doi: 10.3969/j.issn.1674-7445.2019.05.008
摘要：
为了进一步规范肾移植排斥反应的临床诊断与治疗, 中华医学会器官移植学分会组织器官移植学专家, 总结各移植中心的肾移植临床经验, 在《中国肾脏移植排斥反应临床诊疗指南(2016版)》的基础上, 并依据Banff标准, 从超急性排斥反应、急性加速性排斥反应、急性排斥反应、慢性排斥反应等方面, 制订本规范。
为了进一步规范肾移植排斥反应的临床诊断与治疗, 中华医学会器官移植学分会组织器官移植学专家, 总结各移植中心的肾移植临床经验, 在《中国肾脏移植排斥反应临床诊疗指南(2016版)》的基础上, 并依据Banff标准, 从超急性排斥反应、急性加速性排斥反应、急性排斥反应、慢性排斥反应等方面, 制订本规范。
2016, 7(5): 332-338.
doi: 10.3969/j.issn.1674-7445.2016.05.002
摘要：
排斥反应是影响移植肾长期存活的首要独立危险因素，是亟待解决的瓶颈问题。中华医学会器官移植学分会和中国医师协会器官移植医师分会组织国内专家，总结各中心肾移植的临床经验，依据Banff 2013标准，编写了本部指南，希望能为相关临床科室提供工作指引。
排斥反应是影响移植肾长期存活的首要独立危险因素，是亟待解决的瓶颈问题。中华医学会器官移植学分会和中国医师协会器官移植医师分会组织国内专家，总结各中心肾移植的临床经验，依据Banff 2013标准，编写了本部指南，希望能为相关临床科室提供工作指引。
2017, 8(4): 251-259.
doi: 10.3969/j.issn.1674-7445.2017.04.001
摘要：
为了更好地将加速康复外科（ERAS）的理念用于优化重型肝炎肝移植围手术期管理，达到减少并发症、促进患者快速康复的目的，中国医师协会器官移植分会移植免疫学组、中华医学会外科学分会手术学组、广东省医师协会器官移植医师分会组织专家制订了《加速康复外科优化重型肝炎肝移植围手术期管理临床实践的专家共识》。该共识从ERAS优化重型肝炎肝移植术前、术中、术后治疗策略3个方面，总结各移植中心的临床经验，提出相应的专家共识，希望为临床优化重型肝炎肝移植围手术期管理提供参考方案。
为了更好地将加速康复外科（ERAS）的理念用于优化重型肝炎肝移植围手术期管理，达到减少并发症、促进患者快速康复的目的，中国医师协会器官移植分会移植免疫学组、中华医学会外科学分会手术学组、广东省医师协会器官移植医师分会组织专家制订了《加速康复外科优化重型肝炎肝移植围手术期管理临床实践的专家共识》。该共识从ERAS优化重型肝炎肝移植术前、术中、术后治疗策略3个方面，总结各移植中心的临床经验，提出相应的专家共识，希望为临床优化重型肝炎肝移植围手术期管理提供参考方案。
2018, 9(1): 41-50,82.
doi: 10.3969/j.issn.1674-7445.2018.01.006
摘要：
肝移植是目前公认的治疗终末期肝病的最有效措施。经过超过50年的发展，肝移植患者术后存活时间不断延长，并发症的发生率亦有所降低。但是，如何改善供肝短缺的现状、减轻供肝缺血-再灌注损伤，减少并发症的发生率以及进一步提高肝移植患者的远期疗效仍然是困扰肝移植科医师的难题。因此，了解最新的外科技术、多中心临床经验以及相关基础研究结果，将帮助我们更深入地认识疾病本质，为患者制定更妥善的治疗方案。本文综合国际核心期刊报道的内容，对2017年度肝移植相关领域的研究热点及最新进展作一综述，并对今后的研究方向作出展望。
肝移植是目前公认的治疗终末期肝病的最有效措施。经过超过50年的发展，肝移植患者术后存活时间不断延长，并发症的发生率亦有所降低。但是，如何改善供肝短缺的现状、减轻供肝缺血-再灌注损伤，减少并发症的发生率以及进一步提高肝移植患者的远期疗效仍然是困扰肝移植科医师的难题。因此，了解最新的外科技术、多中心临床经验以及相关基础研究结果，将帮助我们更深入地认识疾病本质，为患者制定更妥善的治疗方案。本文综合国际核心期刊报道的内容，对2017年度肝移植相关领域的研究热点及最新进展作一综述，并对今后的研究方向作出展望。
2021, 12(4): 376-383.
doi: 10.3969/j.issn.1674-7445.2021.04.002
Abstract:
2019, 10(3): 213-226.
doi: 10.3969/j.issn.1674-7445.2019.03.001
Abstract:
Competent Authorities: Ministry of Education of the People's Republic of China
Sponsored by: Sun Yat-sen University
Presented by: The Third Affiliated Hospital of Sun Yat-sen University
Editor-in-Chief: Gui-Hua Chen
Publisher: Editorial Office of Organ Transplantation
Address: The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
Postcode: 510630
Tel: 020-38736410
Email: organtranspl@163.com
Postal Code: 46-35
Website: http://www.organtranspl.com
Journal: bimonthly
Price: 20 yuan for each period and 120 yuan for the whole year
CN 44-1665/R
ISSN 1674-7445
Collection
A Guide to the Core Journals of China(2020 Edition)
Source Journals for Chinese Scientific and Technical Papers and Citations
Chinese Science Citation Database(CSCD)
Netherlands Scopus Abstracts and index database
EBSCOhost Online Research Databases(EBSCOhost)
Japan Science & Technology Corporation（JST）
The Western Pacific Region Index Medicus(WPRIM)
Cambridge Scientific Abstracts (CSA)
Ulrich's Periodicals Directory
China National Knowledge Internet(CNKI)
China Science and Technology Journal Database
Diagnosis and treatment of vascular complications after liver transplantation in adults
Reflection on 10 problems of clinical xenotransplantation
Current status and prospect of global development of lung transplantation
Immunosuppressive management in pediatric kidney transplant recipients